1. Yoshimi, Akihide, Lin, Kuan-Ting, Wiseman, Daniel H, Krainer, Adrian R, Abdel-Wahab, Omar. 2019. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. In Nature, 574, 273-277. doi:10.1038/s41586-019-1618-0. https://pubmed.ncbi.nlm.nih.gov/31578525/
2. Wang, Zhiwei, Zhang, Cheng, Guo, Jing, Zhu, Pingping, He, Qiankun. 2024. CRISPR-Cas9 screening identifies INTS3 as an anti-apoptotic RNA-binding protein and therapeutic target for colorectal cancer. In iScience, 27, 109676. doi:10.1016/j.isci.2024.109676. https://pubmed.ncbi.nlm.nih.gov/38665208/
3. Trubnykova, Milana, Bazalar Montoya, Jeny, La Serna-Infantes, Jorge, Castro Mujica, María Del Carmen, Abarca Barriga, Hugo Hernán. 2019. GATAD2B Gene Microdeletion Causing Intellectual Disability Autosomal Dominant Type 18: Case Report and Review of the Literature. In Molecular syndromology, 10, 186-194. doi:10.1159/000499209. https://pubmed.ncbi.nlm.nih.gov/31602190/
4. Vidhyasagar, Venkatasubramanian, He, Yujiong, Guo, Manhong, Lukong, Kiven E, Wu, Yuliang. 2018. Biochemical characterization of INTS3 and C9ORF80, two subunits of hNABP1/2 heterotrimeric complex in nucleic acid binding. In The Biochemical journal, 475, 45-60. doi:10.1042/BCJ20170351. https://pubmed.ncbi.nlm.nih.gov/29150435/
5. Skaar, Jeffrey R, Ferris, Andrea L, Wu, Xiaolin, Hughes, Stephen H, Pagano, Michele. 2015. The Integrator complex controls the termination of transcription at diverse classes of gene targets. In Cell research, 25, 288-305. doi:10.1038/cr.2015.19. https://pubmed.ncbi.nlm.nih.gov/25675981/